Secondary Prevention of coRonary Events After Discharge From Hospital (SPREAD)

This study is currently recruiting participants.
Verified June 2012 by St. John's Research Institute
Sponsor:
Collaborator:
National Heart and Lung Institute
Information provided by (Responsible Party):
Dr Alben Sigamani, St. John's Research Institute
ClinicalTrials.gov Identifier:
NCT01207700
First received: September 22, 2010
Last updated: June 5, 2012
Last verified: June 2012
  Purpose

This is a randomized, open trial comparing post discharge interventions by community health workers (CHW) to standard care in acute coronary syndrome (ACS) patients.

This trial will be conducted in 10 hospitals in India/different parts(both secondary and tertiary care). A total of 800 patients will be recruited, with equal allocation to SPREAD interventions and control groups (usual care)


Condition Intervention
Acute Coronary Syndrome
Behavioral: Community Health Worker, VITA Tool
Other: No intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Supportive Care
Official Title: A Randomized, Open Trial Comparing Post Discharge Interventions to Standard Care

Resource links provided by NLM:


Further study details as provided by St. John's Research Institute:

Primary Outcome Measures:
  • To obtain estimates of rates of adherence to pharmacotherapy and lifestyle modification interventions and the incidence of major cardiovascular events [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Evaluate the rates of adherence to pharmacotherapy and lifestyle modifications using the community health worker

  • To determine the feasibility of conducting a secondary prevention trial using CDCHWs on adherence to medications and lifestyle advice [ Time Frame: 12 MONTHS ] [ Designated as safety issue: No ]
    A pilot study to look at feasibiility of using a trained community health worker to deliver health messages to patients who have had a coronary event


Estimated Enrollment: 800
Study Start Date: August 2011
Estimated Study Completion Date: June 2013
Estimated Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
SPREAD Tools
Home visits by the community health worker, tools for reminders to take medications, material for patients awareness of the importance of secondary prevention
Behavioral: Community Health Worker, VITA Tool
The community Health Worker will use the V
Other Names:
  • A) Patient Reinforcement Form
  • B) Patient Diary
  • D) The VIsual Tool for Adherence (VITA)
  • E) Poster for Life Style Modification & Heart Disease Education
  • F) The Simplified Medication Adherence Questionnaire (SMAQ)
Standard Care
Patients will be followed upto 12 months without a community health worker intervention as per standard practices of the hospital
Other: No intervention
regular hospital based practice
Other Names:
  • clinical follow up
  • post discharge follow up

Detailed Description:

Inclusion criteria:

Consenting patients being discharged after an acute coronary event such as unstable angina, acute myocardial infarction, or after coronary intervention (CABG surgery or PCI).

Exclusion criteria:

Patients with other terminal/ debilitating illness, (e.g., advanced cancer, disabling stroke) those not expected to survive for the study duration, those with dementia and psychiatric illness or patients unlikely to comply with study requirements, including regular follow up.

OUTCOME MEASURES:

  1. Feasibility
  2. Difference in adherence to specific medications for secondary prevention of CAD (Coronary Artery Diseases) compared to the control group, at one year.
  Eligibility

Ages Eligible for Study:   45 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Consenting patients being discharged after an acute coronary event such as unstable angina, acute myocardial infarction, or after coronary intervention (CABG surgery or PCI).

Exclusion Criteria:

  • Patients with other terminal/ debilitating illness, (e.g., advanced cancer, disabling stroke) those not expected to survive for the study duration, those with dementia and psychiatric illness or patients unlikely to comply with study requirements, including regular follow up
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01207700

Contacts
Contact: Dr. Denis Xavier, MD denis@sjri.res.in
Contact: Dr. Alben Sigamani, MD alben@sjri.res.in

Locations
India
Krishna Institute of Medical Science Ltd Recruiting
Secunderabad, Aandhra Pradesh, India, 500003
Contact: Dr. Rajendra Kumar, MD, DM     9848029443        
Contact         kumarpre@hotmail.com    
Principal Investigator: Dr. Rajendra Kumar, MD, DM            
Mahavir Hospital & Research Centre Recruiting
Hyderabad, Andhra Pradesh, India, 500004
Contact: Dr. Sindhu Joshi, DNB     939109991     dr_sindhu@yahoo.com    
Principal Investigator: Dr. Sindhu Joshi, DNB            
Nanjappa Hospital Recruiting
Shimoga, Karnataka, India, 577201
Contact: Dr. J. Narendra, MD, DM     8182225085     jncardiology@gmail.com    
Principal Investigator: Dr. J Narendra, MD, DM            
Caritas Hospital Recruiting
Kottayam, Kerala, India
Contact: Dr.Johny Joseph, MD, DM         drjohnyjoseph@gmail.com    
Principal Investigator: Dr.Johny Joseph, MD, DM            
Bhopal Memorial Hospital Recruiting
Bhopal, Madhya Pradesh, India, 462038
Contact: Dr. Skand K Trivedi, MD, DM            
Principal Investigator: Dr. Skand K Trivedi, MD, DM            
Avanti Institute of Cardiology Recruiting
Nagpur, Maharastra, India, 440012
Contact: Dr. U.K Mahokar, DM, DNB            
Principal Investigator: Dr. U.K Mahokar, MD, DNB            
Poona Hospital Recruiting
Pune, Maharastra, India
Contact: Dr.Jagdish Hiremath     9822022441     jagdish_hiremath@vsnl.net    
Principal Investigator: Dr.Jagdish Hiremath            
Mahatma Gandhi Institute of Medical Science Sevagram Recruiting
Wardha, Maharastra, India, 442001
Contact: Dr.S.P. Kalantri, MD     9970168766     sp.kalantri@gmail.com    
Principal Investigator: Dr.S.P. Kalantri, MD            
Fortis Escorts Hospital Recruiting
Jaipur, Rajasthan, India, 302017
Contact: Dr. Rajeev Gupta, MD, Ph.d            
Principal Investigator: Dr. Rajeev Gupta            
Rajamuthiah Medical College & Hospital Recruiting
Annamalai, Tamil Nadu, India, 608 002
Contact: Dr. N Chidambaram, MD     "9894048397/9345628680"     deanrmmc@yahoo.com    
Principal Investigator: Dr. N Chidambaram, MD            
PSG Hospital Not yet recruiting
Coimbatore, Tamil Nadu, India, 641 004
Contact: Dr T Manikandan, MBBS, DPMR            
Principal Investigator: Dr. T Manikandan, MBBS, DPMR            
Sahara Hospital Recruiting
Lucknow, Uttar Pradesh, India, 226010
Contact: NAKUL SINHA, MD DM         research.sahara@gmail.com    
Contact: SANDEEP MISHRA, MD         research.sahara@gmail.com    
Sanjay Gandhi Post Graduate Institute of Medical Sciences Withdrawn
Lucknow, Uttar Pradesh, India, 226 014
Sir Ganga Ram Hospital Recruiting
New Delhi, India, 110060
Contact: Dr.J P S Sawhney, MD, DM     9810059773     jpssawhney@yahoo.com    
Principal Investigator: Dr.J P S Sawhney, MD, DM            
Sponsors and Collaborators
St. John's Research Institute
National Heart and Lung Institute
Investigators
Principal Investigator: Dr. Rajeev Gupta, MD, PHD Fortis Escorts Hospital, Jaipur
  More Information

No publications provided

Responsible Party: Dr Alben Sigamani, Associate Professor, St. John's Research Institute
ClinicalTrials.gov Identifier: NCT01207700     History of Changes
Other Study ID Numbers: NO1-HV-98215/SJRI - DCT/SPREAD
Study First Received: September 22, 2010
Last Updated: June 5, 2012
Health Authority: India: Indian Council of Medical Research
India: Ministry of Health

Keywords provided by St. John's Research Institute:
post discharge intervention
adherence
compliance
community health worker

Additional relevant MeSH terms:
Acute Coronary Syndrome
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Angina Pectoris
Vascular Diseases
Chest Pain
Pain
Signs and Symptoms
Tocopherols
Antioxidants
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protective Agents
Physiological Effects of Drugs
Vitamins
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on May 23, 2013